Cited by 54Pluripotent Stem Cells ResearchPancreatic function and diabetesDiabetes and associated disorders

HNF4A Haploinsufficiency in MODY1 Abrogates Liver and Pancreas Differentiation from Patient-Derived Induced Pluripotent Stem Cells

Open access
Ng, Natasha Hui Jin, Jasmen, Joanita Binte, Lim, Chang Siang, Lau, Hwee Hui, Krishnan, Vidhya Gomathi, Kadiwala, Juned, Kulkarni, Rohit N., Ræder, Helge +3 more·2019·iScience

Abstract

Maturity-onset diabetes of the young 1 (MODY1) is a monogenic diabetes condition caused by heterozygous HNF4A mutations. We investigate how HNF4A haploinsufficiency from a MODY1/HNF4A mutation influences the development of foregut-derived liver and pancreatic cells through differentiation of human induced pluripotent stem cells from a MODY1 family down the foregut lineage. In MODY1-derived hepatopancreatic progenitors, which expressed reduced HNF4A levels and mislocalized HNF4A, foregut genes were downregulated, whereas hindgut-specifying HOX genes were upregulated. MODY1-derived hepatocyte-like cells were found to exhibit altered morphology. Hepatic and β cell gene signatures were also perturbed in MODY1-derived hepatocyte-like and β-like cells, respectively. As mutant HNF4A (p.Ile271fs) did not undergo complete nonsense-mediated decay or exert dominant negativity, HNF4A-mediated loss of function is likely due to impaired transcriptional activation of target genes. Our results suggest that in MODY1, liver and pancreas development is perturbed early on, contributing to altered hepatic proteins and β cell defects in patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.isci.2019.05.032

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Expression of HNF1A, HNF4A, and FOXA2 typically peaks during the early progenitor stage and decreases toward the final hepatocyte-like cell stage.

    “This finding is consistent with other reports that these genes’ expression typically peaks during early progenitor stage and decreases towards the final hepatocyte-like cells stage24–26.”

    From ​Temporal proteomic profiling of iPSC-derived human liver organoids reveals optimal maturation for drug metabolism and toxicology (2026) · cites this paper as [25]

    The Results section ('MODY1-Mediated Loss of HNF4A Transcriptional Function Affects Subsequent Hepatic and Pancreatic Development Signatures'; page unavailable) reports that HNF4A expression peaked on day 8 of differentiation into hepatocyte-like cells, before other hepatic genes peaked on days 16 or 24. Our copy does not establish the same early peak and subsequent decline for HNF1A or FOXA2, so it supports only the HNF4A part of the claim. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ng, N. H. J., Jasmen, J. B., Lim, C. S., Lau, H. H., Krishnan, V. G., Kadiwala, J., Kulkarni, R. N., Ræder, H., Vallier, L., Hoon, S., & Teo, A. K. K.
Affiliations
  • Agency for Science, Technology and Research (SG)
  • Wellcome/MRC Cambridge Stem Cell Institute (GB)
  • Brigham and Women's Hospital (US)
  • Haukeland University Hospital (NO)
Corresponding author
Teo, Adrian Kee Keong
Venue
iScience
Publisher
Elsevier BV
Published
2019-06
Volume
16
Pages
192-205
ISSN
2589-0042 (ISSN-L)
OpenAlex
W2946912605
Cited by
54
References
60
Citations by year
2026: 6 · 2025: 5 · 2024: 8 · 2023: 8 · 2022: 7 · 2021: 10 · 2020: 5 · 2019: 4 · 2017: 1
FWCI
2.15
Type
journal article
Language
en
Open access
Locations
  • iScience (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by-nc-nd)
  • National University of Singapore (submittedVersion, cc-by-nc-nd)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DR-NTU (Nanyang Technological University) (submittedVersion, cc-by-nc-nd)
  • Apollo
Funders
  • Institute of Molecular and Cell Biology
  • Medical Research Council
  • Novo Nordisk Fonden
  • European Research Council
  • Agency for Science, Technology and Research (15302FG148)
  • National Institutes of Health (RO1 067536)
  • National Medical Research Council
  • Helse Vest Regionalt Helseføretak
  • Wellcome Trust
  • Lee Foundation (SHTX/LFG/002/2018, SIG18011)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
HNF4α, MODY1, haploinsufficiency, monogenic diabetes, induced pluripotent stem cells, hepatocyte differentiation, pancreatic beta cell differentiation, foregut development, nonsense-mediated mRNA decay, dominant negative effect, transcriptional activation, Hox genes, liver development

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review